Analyst Price Target is $4.33
▲ +403.88% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Lucid Diagnostics in the last 3 months. The average price target is $4.33, with a high forecast of $7.50 and a low forecast of $2.50. The average price target represents a 403.88% upside from the last price of $0.86.
Current Consensus is
Buy
The current consensus among 3 contributing investment analysts is to buy stock in Lucid Diagnostics. This Buy consensus rating has held steady for over two years.